Devyn Smith is Chief Operating Officer for Sigilon Therapeutics, a biotech company. He is tasked with building out the strategy and operational elements for a portfolio of potential new medicines. Prior to Sigilon, Devyn was part of Pfizer’s Medicinal Sciences Division of R&D as Head of Business Operations & Strategy. The focus of this role…Read more

Brahm Goldstein, MD, MCR joined CSL Behring in 2018 and is the Therapeutic Area Head for Hematology & Thrombosis and Executive Director, Clinical Research and Development in King of Prussia, PA, USA. Brahm has an MD degree from SUNY Health Science Center and a Masters in Clinical Research from Oregon Health & Science University. He…Read more